No increase of the blood oxygenation level-dependent functional magnetic resonance imaging signal with higher field strength: implications for brain activation studies.
Experimental data up to 7.0 T show that the blood oxygenation level-dependent (BOLD) signal of functional magnetic resonance imaging (fMRI) increases with higher magnetic field strength. Although several studies at 11.7 T report higher BOLD signal compared with studies at 7.0 T, no direct comparison at these two field strengths has been performed under the exact same conditions. It therefore remains unclear whether the expected increase of BOLD effect with field strength will still continue to hold for fields >7.0 T. To examine this issue, we compared the BOLD activation signal at 7.0 and 11.7 T with the two common sequences, spin-echo (SE) and gradient-echo (GE) echo planar imaging (EPI). We chose the physiologically well controlled rat model of electrical forepaw stimulation under medetomidine sedation. While a linear to superlinear increase in activation with field strengths up to 7.0 T was reported in the literature, we observed no significant activation difference between 7.0 and 11.7 T with either SE or GE. Discussing the results in light of the four-component model of the BOLD signal, we showed that at high field only two extravascular contributions remain relevant, while both intravascular components vanish. Constancy of the BOLD effect is discussed due to motional narrowing, i.e., susceptibility gradients become so strong that phase variance of diffusing spins decreases and therefore the BOLD signal also decreases. This finding will be of high significance for the planning of future human and animal fMRI studies at high fields and their quantitative analysis.
Seehafer
Jörg U
JU
In-Vivo NMR Laboratory, Max Planck Institute for Neurological Research, D-50931 Cologne, Germany.
Kalthoff
Daniel
D
Farr
Tracy D
TD
Wiedermann
Dirk
D
Hoehn
Mathias
M
D000818:Animals; D001921:Brain / Q000098:blood supply / Q000502:physiology*; D004558:Electric Stimulation; D005552:Forelimb / Q000502:physiology; D008279:Magnetic Resonance Imaging / Q000295:instrumentation* / Q000379:methods*; D008297:Male; D023421:Models, Animal; D010100:Oxygen / Q000097:blood*; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D055698:Touch Perception / Q000502:physiology
D010100:Oxygen
Magn Reson Med. 2006 Aug;56(2):386-94
16767752
Magn Reson Med. 1993 Feb;29(2):277-9
8429797
NMR Biomed. 2008 May;21(4):410-6
18435491
J Magn Reson Imaging. 2003 Nov;18(5):519-29
14579394
Neuroimage. 2007 Apr 1;35(2):539-52
17306989
J Magn Reson Imaging. 2006 Jun;23(6):794-807
16649206
Magn Reson Med. 2006 Dec;56(6):1274-82
17075852
NMR Biomed. 1994 Mar;7(1-2):12-20
8068520
Magn Reson Med. 2001 Oct;46(4):723-34
11590649
Neuroimage. 2008 Jan 1;39(1):248-60
17904868
J Cereb Blood Flow Metab. 1994 Jul;14(4):649-55
8014212
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15182-7
12407177
Biophys J. 1993 Mar;64(3):803-12
8386018
MAGMA. 2004 Dec;17(3-6):313-6
15580376
J Neurosci. 2009 Feb 11;29(6):1707-18
19211878
Neuroimage. 2004 Oct;23(2):613-24
15488411
Magn Reson Med. 1994 Jan;31(1):9-21
8121277
J Neurosci. 2006 Aug 16;26(33):8409-16
16914666
Magn Reson Med. 2001 Mar;45(3):397-408
11241696
Magn Reson Med. 2003 Jun;49(6):1019-27
12768579
Magn Reson Med. 1999 Nov;42(5):919-28
10542351
Magn Reson Med. 2001 Feb;45(2):233-46
11180431
Neuroimage. 2006 Feb 15;29(4):1303-10
16223588
Neuroimage. 1999 Apr;9(4):446-51
10191173
NMR Biomed. 2005 Nov;18(7):440-6
16158460
Eur J Radiol. 2003 Nov;48(2):138-45
14680904
MAGMA. 2008 Mar;21(1-2):103-11
18183443
J Neurosci. 2008 Jan 30;28(5):1022-9
18234880
Magn Reson Med. 1999 Mar;41(3):469-73
10204868
Neuroimage. 2004;23 Suppl 1:S208-19
15501092
Neuroimage. 2009 Oct 15;48(1):150-65
19481163
Behav Res Methods. 2007 May;39(2):175-91
17695343
Neuroimage. 2006 May 1;30(4):1149-60
16414284
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72
2124706
Magn Reson Med. 2004 Jul;52(1):89-99
15236371
J Neurosci Methods. 2006 Mar 15;151(2):268-75
16168491